MDA Clinical & Scientific Conference

March 16, 2022 at 8:50 AM EDT

CEO Dr. James McArthur and VP of Clinical Science Dr. Jane Larkindale to present abstract, “Unlocking the potential of oligonucleotide therapeutics for Duchenne muscular dystrophy through enhanced delivery”

Back to top